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Regenerative medicine, including stem cell based therapies and xenotransplantation, is a new and 
developing field that aims to restore normal function in end stage cell/organ failure. However, transfer of 
cells with a different genetic background, will expose the recipient to non-self cell surface antigenic 
determinants that may evoke an immune response and subsequent graft damage. Thus, the cell surface 
antigen expression of cells aimed for transplantation has to be defined. 
 
The first part of this study deals with glycosphingolipids of human embryonic stem cells (hESC). The 
glycosphingolipids were isolated from a relatively high number of cells (1x109 cells/cell line) allowing 
separation of the glycosphingolipids into total non-acid and acid fractions, that could be further separated 
into sub-fractions. These fractions were structurally characterized by mass spectrometry, proton NMR 
spectroscopy and binding studies with carbohydrate binding ligands. This allowed identification of 
several glycosphingolipids not previously described in hESC. In the non-acid glycosphingolipid fractions 
several novel blood group H, Lex and Ley compounds based on neolacto core chains were characterized. 
The acid glycosphingolipid fractions contained several novel hESC acid glycosphingolipids, like the 
gangliosides sialyl-globotetraosylceramide and sialyl-lactotetraosylceramide, and the sulfated 
glycosphingolipids sulfatide, sulf-lactosylceramide and sulf-globopentaosylceramide. The cellular and 
subcellular distribution of sialyl-lactotetraosylceramide and sulfated glycosphingolipids in hESC and in 
human induced pluripotent stem cells (hiPSC) was explored by flow cytometry, immunohistochemistry 
and electron microscopy. A high cell surface expression of sialyl-lactotetra on hESC and hiPSC was 
demonstrated, whereas the sulfated glycosphingolipids were restricted to intracellular compartments. 
During differentiation of hiPSC into hepatocyte-like cells a rapid down-regulation of the sialyl-lactotetra 
epitope was found. Taken together these data demonstrate that the sialyl-lactotetra carbohydrate 
sequence is a novel marker for undifferentiated human pluripotent stem cells. 
 
Diseased human heart valves are substituted with either mechanical valves or biological heart valves 
(BHV) produced from porcine and bovine valves or pericardial tissues. The BHV function deteriorates 
with time partly due to an immunological process. The second part of the study aimed at defining 
carbohydrate antigens of porcine heart valves with a potential of being immune targets for this process. 
Here, a number of acid glycosphingolipids as sulfatide and various gangliosides, and non-acid 
glycosphingolipids, as Galα3-neolactotetraosylceramide were characterized. Interestingly, no 
gangliosides with the non-Gal xenoantigen NeuGc were found. However, the Galα3 epitope is the major 
xenoantigen, and thus a possible target for antibody mediated immune reactions to xenogeneic 
bioprosthetic heart valves in humans.  
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